Delivery Order SPE2DP16D0009-0136
Award Date
9/16/16
Potential Completion Date
12/15/16
Potential Value
$896K
Federal Agency
Medical Supply Chain
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The $331,245.90 firm fixed price delivery order is for the antiviral medication zanamivir. There is no set-aside designation for this award. Glaxosmithkline has held other federal contracts and grants,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline. The contract is for the delivery of zanamivir, an antiviral medication, with a potential value of $361,912.00. The contract is a firm fixed price Delivery Order, with no set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range of products and services to U.S. government agencies, including vaccines, antiviral...
This is a federal contract award from the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of zanamivir, an antiviral medication, with a potential value of $118,463.40. It is a firm fixed price delivery order contract, with no set-aside designation. Glaxosmithkline has received multiple federal contracts and...
This federal contract award, SPE2DP16D0009/0020, was issued by the Defense Logistics Agency (DLA) to the prime contractor Glaxosmithkline, LLC. The $312,660.00 firm fixed price delivery order is for the antiviral medication zanamivir. The contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in North Carolina. Glaxosmithkline is a pharmaceutical company that provides vaccines, antivirals, and other products to various U.S. government agencies...
This federal contract award, SPE2DP18D0010|SPE2DP18F5904, was issued by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other products to U.S. government agencies. The contract is for the delivery of the antiviral medication zanamivir, with a total ceiling value of $92,628.80 and a completion date of February 19, 2019. The contract is a firm fixed price delivery order, with no...
This contract award to Glaxosmithkline, LLC, a pharmaceutical company, was issued by the Defense Logistics Agency Troop Support Medical. The $414,326.61 firm fixed price purchase order is for the antiviral medication zanamivir. The contract has no set-aside designation and the place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies through federal contracts, including influenza vaccines,...
This is a federal contract award made by the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, for the provision of the antiviral medication zanamivir. The contract is a delivery order with a firm fixed price of $5,486.25 and a completion date of March 18, 2024. The contract does not have a set-aside designation. Glaxosmithkline has a range of federal contracts and grants to supply pharmaceutical products, vaccines, and antiviral...
This is a federal delivery order contract awarded by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC for the supply of the antiviral medication zanamivir for inhalation. The contract has a ceiling value of $325,166.40 and was awarded on a firm fixed price basis with no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and grants, including influenza...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a foreign-owned, for-profit pharmaceutical company. The contract is for the supply of zanamivir, an antiviral medication, with a potential value of $162,184.00. The contract does not have a set-aside designation and the place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has provided a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of the antiviral medication zanamivir. The contract has a ceiling value of $80,651.20 and a completion date of February 19, 2019. The contract is not set aside for any particular business type. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies, including the Departments...